FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…